The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Viral Vector and Plasmid DNA Testing Service Market Research Report 2025

Global Viral Vector and Plasmid DNA Testing Service Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1987654

No of Pages : 90

Ask Your Query
Synopsis
Viral vectors are widely used in gene therapies. The viral vectors are majorly used by researchers to deliver genetic materials in the cells. Viral vectors are playing significant role in the pharmaceutical sector, as many research and innovations are ongoing for the development of drugs for treating cancer, cardiovascular diseases, ophthalmology, hematology, and many others.
The global Viral Vector and Plasmid DNA Testing Service market was valued at US$ 234.5 million in 2023 and is anticipated to reach US$ 1039.6 million by 2030, witnessing a CAGR of 23.5% during the forecast period 2024-2030.
The Viral Vector and Plasmid DNA Testing Service market is driven by the increasing demand for accurate and reliable testing services to ensure the safety and quality of gene therapies and vaccines using viral vectors and plasmid DNA. Testing services play a crucial role in assessing the potency, purity, and identity of these biopharmaceutical products before clinical use. The growing focus on gene-based therapies and the development of innovative treatments for various diseases contribute to market growth. Moreover, regulatory requirements mandating stringent testing standards further propel adoption. However, challenges include the complexity of testing methods and the need for specialized expertise and equipment. Addressing potential cross-contamination, ensuring consistency in testing results, and adhering to evolving regulatory guidelines are ongoing concerns. The market's success relies on continuous research to develop advanced testing methodologies, robust quality control measures, and collaborations between testing laboratories and pharmaceutical companies to offer accurate, efficient, and compliant viral vector and plasmid DNA testing services while navigating the evolving challenges associated with biopharmaceutical testing.
This report aims to provide a comprehensive presentation of the global market for Viral Vector and Plasmid DNA Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector and Plasmid DNA Testing Service.
Report Scope
The Viral Vector and Plasmid DNA Testing Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Vector and Plasmid DNA Testing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Vector and Plasmid DNA Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
Segment by Type
Safety
Genetic Characterization
Purity
Identity
Potency
Segment by Application
Research Organizations
Pharmaceutical
Biotechnological Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Vector and Plasmid DNA Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector and Plasmid DNA Testing Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Safety
1.2.3 Genetic Characterization
1.2.4 Purity
1.2.5 Identity
1.2.6 Potency
1.3 Market by Application
1.3.1 Global Viral Vector and Plasmid DNA Testing Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Organizations
1.3.3 Pharmaceutical
1.3.4 Biotechnological Companies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector and Plasmid DNA Testing Service Market Perspective (2019-2030)
2.2 Viral Vector and Plasmid DNA Testing Service Growth Trends by Region
2.2.1 Global Viral Vector and Plasmid DNA Testing Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Vector and Plasmid DNA Testing Service Historic Market Size by Region (2019-2024)
2.2.3 Viral Vector and Plasmid DNA Testing Service Forecasted Market Size by Region (2025-2030)
2.3 Viral Vector and Plasmid DNA Testing Service Market Dynamics
2.3.1 Viral Vector and Plasmid DNA Testing Service Industry Trends
2.3.2 Viral Vector and Plasmid DNA Testing Service Market Drivers
2.3.3 Viral Vector and Plasmid DNA Testing Service Market Challenges
2.3.4 Viral Vector and Plasmid DNA Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector and Plasmid DNA Testing Service Players by Revenue
3.1.1 Global Top Viral Vector and Plasmid DNA Testing Service Players by Revenue (2019-2024)
3.1.2 Global Viral Vector and Plasmid DNA Testing Service Revenue Market Share by Players (2019-2024)
3.2 Global Viral Vector and Plasmid DNA Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vector and Plasmid DNA Testing Service Revenue
3.4 Global Viral Vector and Plasmid DNA Testing Service Market Concentration Ratio
3.4.1 Global Viral Vector and Plasmid DNA Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector and Plasmid DNA Testing Service Revenue in 2023
3.5 Viral Vector and Plasmid DNA Testing Service Key Players Head office and Area Served
3.6 Key Players Viral Vector and Plasmid DNA Testing Service Product Solution and Service
3.7 Date of Enter into Viral Vector and Plasmid DNA Testing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector and Plasmid DNA Testing Service Breakdown Data by Type
4.1 Global Viral Vector and Plasmid DNA Testing Service Historic Market Size by Type (2019-2024)
4.2 Global Viral Vector and Plasmid DNA Testing Service Forecasted Market Size by Type (2025-2030)
5 Viral Vector and Plasmid DNA Testing Service Breakdown Data by Application
5.1 Global Viral Vector and Plasmid DNA Testing Service Historic Market Size by Application (2019-2024)
5.2 Global Viral Vector and Plasmid DNA Testing Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Vector and Plasmid DNA Testing Service Market Size (2019-2030)
6.2 North America Viral Vector and Plasmid DNA Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Vector and Plasmid DNA Testing Service Market Size by Country (2019-2024)
6.4 North America Viral Vector and Plasmid DNA Testing Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector and Plasmid DNA Testing Service Market Size (2019-2030)
7.2 Europe Viral Vector and Plasmid DNA Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Vector and Plasmid DNA Testing Service Market Size by Country (2019-2024)
7.4 Europe Viral Vector and Plasmid DNA Testing Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector and Plasmid DNA Testing Service Market Size (2019-2030)
8.2 Asia-Pacific Viral Vector and Plasmid DNA Testing Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Vector and Plasmid DNA Testing Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Vector and Plasmid DNA Testing Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector and Plasmid DNA Testing Service Market Size (2019-2030)
9.2 Latin America Viral Vector and Plasmid DNA Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Vector and Plasmid DNA Testing Service Market Size by Country (2019-2024)
9.4 Latin America Viral Vector and Plasmid DNA Testing Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector and Plasmid DNA Testing Service Market Size (2019-2030)
10.2 Middle East & Africa Viral Vector and Plasmid DNA Testing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Vector and Plasmid DNA Testing Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Vector and Plasmid DNA Testing Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioReliance
11.1.1 BioReliance Company Detail
11.1.2 BioReliance Business Overview
11.1.3 BioReliance Viral Vector and Plasmid DNA Testing Service Introduction
11.1.4 BioReliance Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.1.5 BioReliance Recent Development
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Detail
11.2.2 Cobra Biologics Business Overview
11.2.3 Cobra Biologics Viral Vector and Plasmid DNA Testing Service Introduction
11.2.4 Cobra Biologics Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.2.5 Cobra Biologics Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Detail
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Viral Vector and Plasmid DNA Testing Service Introduction
11.3.4 Oxford BioMedica Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.3.5 Oxford BioMedica Recent Development
11.4 UniQure
11.4.1 UniQure Company Detail
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vector and Plasmid DNA Testing Service Introduction
11.4.4 UniQure Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.4.5 UniQure Recent Development
11.5 FinVector
11.5.1 FinVector Company Detail
11.5.2 FinVector Business Overview
11.5.3 FinVector Viral Vector and Plasmid DNA Testing Service Introduction
11.5.4 FinVector Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.5.5 FinVector Recent Development
11.6 MolMed
11.6.1 MolMed Company Detail
11.6.2 MolMed Business Overview
11.6.3 MolMed Viral Vector and Plasmid DNA Testing Service Introduction
11.6.4 MolMed Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.6.5 MolMed Recent Development
11.7 MassBiologics
11.7.1 MassBiologics Company Detail
11.7.2 MassBiologics Business Overview
11.7.3 MassBiologics Viral Vector and Plasmid DNA Testing Service Introduction
11.7.4 MassBiologics Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.7.5 MassBiologics Recent Development
11.8 Richter-Helm
11.8.1 Richter-Helm Company Detail
11.8.2 Richter-Helm Business Overview
11.8.3 Richter-Helm Viral Vector and Plasmid DNA Testing Service Introduction
11.8.4 Richter-Helm Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.8.5 Richter-Helm Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Testing Service Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Viral Vector and Plasmid DNA Testing Service Introduction
11.10.4 Lonza Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.10.5 Lonza Recent Development
11.11 Aldevron
11.11.1 Aldevron Company Detail
11.11.2 Aldevron Business Overview
11.11.3 Aldevron Viral Vector and Plasmid DNA Testing Service Introduction
11.11.4 Aldevron Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.11.5 Aldevron Recent Development
11.12 Eurogentec
11.12.1 Eurogentec Company Detail
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Viral Vector and Plasmid DNA Testing Service Introduction
11.12.4 Eurogentec Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.12.5 Eurogentec Recent Development
11.13 Cell and Gene Therapy Catapult
11.13.1 Cell and Gene Therapy Catapult Company Detail
11.13.2 Cell and Gene Therapy Catapult Business Overview
11.13.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Testing Service Introduction
11.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.13.5 Cell and Gene Therapy Catapult Recent Development
11.14 Biovian
11.14.1 Biovian Company Detail
11.14.2 Biovian Business Overview
11.14.3 Biovian Viral Vector and Plasmid DNA Testing Service Introduction
11.14.4 Biovian Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.14.5 Biovian Recent Development
11.15 Brammer Bio
11.15.1 Brammer Bio Company Detail
11.15.2 Brammer Bio Business Overview
11.15.3 Brammer Bio Viral Vector and Plasmid DNA Testing Service Introduction
11.15.4 Brammer Bio Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
11.15.5 Brammer Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Viral Vector and Plasmid DNA Testing Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Safety
Table 3. Key Players of Genetic Characterization
Table 4. Key Players of Purity
Table 5. Key Players of Identity
Table 6. Key Players of Potency
Table 7. Global Viral Vector and Plasmid DNA Testing Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Viral Vector and Plasmid DNA Testing Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Viral Vector and Plasmid DNA Testing Service Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Viral Vector and Plasmid DNA Testing Service Market Share by Region (2019-2024)
Table 11. Global Viral Vector and Plasmid DNA Testing Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Viral Vector and Plasmid DNA Testing Service Market Share by Region (2025-2030)
Table 13. Viral Vector and Plasmid DNA Testing Service Market Trends
Table 14. Viral Vector and Plasmid DNA Testing Service Market Drivers
Table 15. Viral Vector and Plasmid DNA Testing Service Market Challenges
Table 16. Viral Vector and Plasmid DNA Testing Service Market Restraints
Table 17. Global Viral Vector and Plasmid DNA Testing Service Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Viral Vector and Plasmid DNA Testing Service Market Share by Players (2019-2024)
Table 19. Global Top Viral Vector and Plasmid DNA Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector and Plasmid DNA Testing Service as of 2023)
Table 20. Ranking of Global Top Viral Vector and Plasmid DNA Testing Service Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Viral Vector and Plasmid DNA Testing Service Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Viral Vector and Plasmid DNA Testing Service Product Solution and Service
Table 24. Date of Enter into Viral Vector and Plasmid DNA Testing Service Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Viral Vector and Plasmid DNA Testing Service Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Viral Vector and Plasmid DNA Testing Service Revenue Market Share by Type (2019-2024)
Table 28. Global Viral Vector and Plasmid DNA Testing Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Viral Vector and Plasmid DNA Testing Service Revenue Market Share by Type (2025-2030)
Table 30. Global Viral Vector and Plasmid DNA Testing Service Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Viral Vector and Plasmid DNA Testing Service Revenue Market Share by Application (2019-2024)
Table 32. Global Viral Vector and Plasmid DNA Testing Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Viral Vector and Plasmid DNA Testing Service Revenue Market Share by Application (2025-2030)
Table 34. North America Viral Vector and Plasmid DNA Testing Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Viral Vector and Plasmid DNA Testing Service Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Viral Vector and Plasmid DNA Testing Service Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Viral Vector and Plasmid DNA Testing Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Viral Vector and Plasmid DNA Testing Service Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Viral Vector and Plasmid DNA Testing Service Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Viral Vector and Plasmid DNA Testing Service Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Viral Vector and Plasmid DNA Testing Service Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Viral Vector and Plasmid DNA Testing Service Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Viral Vector and Plasmid DNA Testing Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Viral Vector and Plasmid DNA Testing Service Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Viral Vector and Plasmid DNA Testing Service Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Viral Vector and Plasmid DNA Testing Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Viral Vector and Plasmid DNA Testing Service Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Viral Vector and Plasmid DNA Testing Service Market Size by Country (2025-2030) & (US$ Million)
Table 49. BioReliance Company Detail
Table 50. BioReliance Business Overview
Table 51. BioReliance Viral Vector and Plasmid DNA Testing Service Product
Table 52. BioReliance Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024) & (US$ Million)
Table 53. BioReliance Recent Development
Table 54. Cobra Biologics Company Detail
Table 55. Cobra Biologics Business Overview
Table 56. Cobra Biologics Viral Vector and Plasmid DNA Testing Service Product
Table 57. Cobra Biologics Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024) & (US$ Million)
Table 58. Cobra Biologics Recent Development
Table 59. Oxford BioMedica Company Detail
Table 60. Oxford BioMedica Business Overview
Table 61. Oxford BioMedica Viral Vector and Plasmid DNA Testing Service Product
Table 62. Oxford BioMedica Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024) & (US$ Million)
Table 63. Oxford BioMedica Recent Development
Table 64. UniQure Company Detail
Table 65. UniQure Business Overview
Table 66. UniQure Viral Vector and Plasmid DNA Testing Service Product
Table 67. UniQure Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024) & (US$ Million)
Table 68. UniQure Recent Development
Table 69. FinVector Company Detail
Table 70. FinVector Business Overview
Table 71. FinVector Viral Vector and Plasmid DNA Testing Service Product
Table 72. FinVector Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024) & (US$ Million)
Table 73. FinVector Recent Development
Table 74. MolMed Company Detail
Table 75. MolMed Business Overview
Table 76. MolMed Viral Vector and Plasmid DNA Testing Service Product
Table 77. MolMed Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024) & (US$ Million)
Table 78. MolMed Recent Development
Table 79. MassBiologics Company Detail
Table 80. MassBiologics Business Overview
Table 81. MassBiologics Viral Vector and Plasmid DNA Testing Service Product
Table 82. MassBiologics Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024) & (US$ Million)
Table 83. MassBiologics Recent Development
Table 84. Richter-Helm Company Detail
Table 85. Richter-Helm Business Overview
Table 86. Richter-Helm Viral Vector and Plasmid DNA Testing Service Product
Table 87. Richter-Helm Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024) & (US$ Million)
Table 88. Richter-Helm Recent Development
Table 89. FUJIFILM Diosynth Biotechnologies Company Detail
Table 90. FUJIFILM Diosynth Biotechnologies Business Overview
Table 91. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Testing Service Product
Table 92. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024) & (US$ Million)
Table 93. FUJIFILM Diosynth Biotechnologies Recent Development
Table 94. Lonza Company Detail
Table 95. Lonza Business Overview
Table 96. Lonza Viral Vector and Plasmid DNA Testing Service Product
Table 97. Lonza Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024) & (US$ Million)
Table 98. Lonza Recent Development
Table 99. Aldevron Company Detail
Table 100. Aldevron Business Overview
Table 101. Aldevron Viral Vector and Plasmid DNA Testing Service Product
Table 102. Aldevron Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024) & (US$ Million)
Table 103. Aldevron Recent Development
Table 104. Eurogentec Company Detail
Table 105. Eurogentec Business Overview
Table 106. Eurogentec Viral Vector and Plasmid DNA Testing Service Product
Table 107. Eurogentec Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024) & (US$ Million)
Table 108. Eurogentec Recent Development
Table 109. Cell and Gene Therapy Catapult Company Detail
Table 110. Cell and Gene Therapy Catapult Business Overview
Table 111. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Testing Service Product
Table 112. Cell and Gene Therapy Catapult Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024) & (US$ Million)
Table 113. Cell and Gene Therapy Catapult Recent Development
Table 114. Biovian Company Detail
Table 115. Biovian Business Overview
Table 116. Biovian Viral Vector and Plasmid DNA Testing Service Product
Table 117. Biovian Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024) & (US$ Million)
Table 118. Biovian Recent Development
Table 119. Brammer Bio Company Detail
Table 120. Brammer Bio Business Overview
Table 121. Brammer Bio Viral Vector and Plasmid DNA Testing Service Product
Table 122. Brammer Bio Revenue in Viral Vector and Plasmid DNA Testing Service Business (2019-2024) & (US$ Million)
Table 123. Brammer Bio Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vector and Plasmid DNA Testing Service Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Viral Vector and Plasmid DNA Testing Service Market Share by Type: 2023 VS 2030
Figure 3. Safety Features
Figure 4. Genetic Characterization Features
Figure 5. Purity Features
Figure 6. Identity Features
Figure 7. Potency Features
Figure 8. Global Viral Vector and Plasmid DNA Testing Service Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Viral Vector and Plasmid DNA Testing Service Market Share by Application: 2023 VS 2030
Figure 10. Research Organizations Case Studies
Figure 11. Pharmaceutical Case Studies
Figure 12. Biotechnological Companies Case Studies
Figure 13. Viral Vector and Plasmid DNA Testing Service Report Years Considered
Figure 14. Global Viral Vector and Plasmid DNA Testing Service Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Viral Vector and Plasmid DNA Testing Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Viral Vector and Plasmid DNA Testing Service Market Share by Region: 2023 VS 2030
Figure 17. Global Viral Vector and Plasmid DNA Testing Service Market Share by Players in 2023
Figure 18. Global Top Viral Vector and Plasmid DNA Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector and Plasmid DNA Testing Service as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Viral Vector and Plasmid DNA Testing Service Revenue in 2023
Figure 20. North America Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Viral Vector and Plasmid DNA Testing Service Market Share by Country (2019-2030)
Figure 22. United States Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Viral Vector and Plasmid DNA Testing Service Market Share by Country (2019-2030)
Figure 26. Germany Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Viral Vector and Plasmid DNA Testing Service Market Share by Region (2019-2030)
Figure 34. China Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Viral Vector and Plasmid DNA Testing Service Market Share by Country (2019-2030)
Figure 42. Mexico Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Viral Vector and Plasmid DNA Testing Service Market Share by Country (2019-2030)
Figure 46. Turkey Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Viral Vector and Plasmid DNA Testing Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. BioReliance Revenue Growth Rate in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
Figure 49. Cobra Biologics Revenue Growth Rate in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
Figure 50. Oxford BioMedica Revenue Growth Rate in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
Figure 51. UniQure Revenue Growth Rate in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
Figure 52. FinVector Revenue Growth Rate in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
Figure 53. MolMed Revenue Growth Rate in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
Figure 54. MassBiologics Revenue Growth Rate in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
Figure 55. Richter-Helm Revenue Growth Rate in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
Figure 56. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
Figure 57. Lonza Revenue Growth Rate in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
Figure 58. Aldevron Revenue Growth Rate in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
Figure 59. Eurogentec Revenue Growth Rate in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
Figure 60. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
Figure 61. Biovian Revenue Growth Rate in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
Figure 62. Brammer Bio Revenue Growth Rate in Viral Vector and Plasmid DNA Testing Service Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock